Switch to PDF version
Audio Broadcast Version
Ammonia-Caffeine-Pheniramine Solution 100 ml
Release time:
2024-10-28
Font scaling:
【Drug Name】
English Name: Paracetamol Caffeine Guaifenesin and Chlorphenamine Maleate SolutionPinyin: An Kayu Min Rongye
【Ingredients】
Action Category
【Characteristics】
Indications
Specifications
Dosage and Administration
| Age 1-3 years old | Weight: 10–15 kg | Single dose: 4-5 ml | If fever or pain does not subside, you may take another dose every 4 to 6 hours, but no more than 4 doses within 24 hours. |
| Age 4-6 years old | Weight: 16–21 kg | Dosage per use: 5–7 milliliters | If fever or pain does not subside, you may take another dose every 4 to 6 hours, but no more than 4 doses within 24 hours. |
| Ages 7-9 | Weight: 22–27 kg | Single dose: 7–9 milliliters | If fever or pain does not subside, you may take another dose every 4 to 6 hours, but no more than 4 doses within 24 hours. |
| Age 10-12 years old | Weight: 28-32 kg | Dosage per use: 9-10 milliliters | If fever or pain does not subside, you may take another dose every 4 to 6 hours, but no more than 4 doses within 24 hours. |
Adverse reaction
Sometimes, mild symptoms such as dizziness, fatigue, nausea, upper abdominal discomfort, dry mouth, loss of appetite, and rash may occur, but these usually resolve on their own.
Taboo
Precautions
1. If symptoms do not improve after 3 to 7 days of medication, please consult a physician or pharmacist.
2. Do not drink alcohol or alcoholic beverages while taking this product.
3. Children under 1 year old should use this product under the guidance of a physician.
4. Combining cold medications containing the same or similar active ingredients should be avoided.
5. Patients with gastrointestinal ulcers, benign prostatic hyperplasia, glaucoma, and elderly individuals should use this product under the guidance of a physician.
6. Use with caution in patients with hepatic or renal impairment.
7. Use with caution during pregnancy and breastfeeding.
8. During medication, do not drive machinery, vehicles, or ships, engage in high-altitude work, perform mechanical operations, or operate precision instruments.
9. If you take an overdose or experience severe adverse reactions, seek medical attention immediately.
10. Do not use if you are allergic to this product; use with caution if you have an allergic disposition.
11. Do not use this product if its appearance has changed.
12. Please keep this product out of reach of children.
13. Children must use this product under adult supervision.
14. If you are currently taking other medications, please consult your doctor or pharmacist before using this product.
15. It is not recommended that parents or guardians administer this product to infants and toddlers under the age of 2 without first consulting a physician or pharmacist.
16. Use the medication strictly according to the dosage and administration instructions provided in the drug’s package insert to avoid overdosing.
Drug interactions
1. When used in combination with other antipyretic and analgesic drugs, the risk of nephrotoxicity may increase.
2. This product should not be used concurrently with chloramphenicol, barbiturates (such as phenobarbital), or similar substances.
3. If used concurrently with other medications, drug interactions may occur. For details, please consult your doctor or pharmacist.
Pharmacological effects
Storage
Packaging
Validity period
Implementation standard
Approval Number
[Instruction Manual Revision Date]
【Marketing Authorization Holder】
Company Name: Guizhou Finder Pharmaceutical Co.Ltd.
Registered Address: Building B, Jinghong Industrial Park, No. 338 Baiyun North Road, Baiyun District, Guiyang City, Guizhou Province; Postal Code: 550014
Phone numbers: 0851-84832198, 84833768
【Manufacturing Enterprise】
Production Address: Building B, Jinghong Industrial Park, No. 338 Baiyun North Road, Baiyun District, Guiyang City, Guizhou Province; Postal Code: 550014
Phone numbers: 0851-84832198, 84833768
Fax number: 0851-84612567
Website: http://www.gzfd.com.cn For any questions, please contact the marketing authorization holder.